PDL BioPharma

YTD

ALL

Why Robinhood?

You can watch PDL BioPharma and buy or sell other stocks, ETFs, and their options commission-free!

About PDLI

PDL BioPharma, Inc. engages in intellectual property asset management, and patent portfolio and related assets investment activities. Intellectual Property Patents The company has been issued patents in the United States and elsewhere, covering the humanization of antibodies, which are referred to as its Queen et al. patents.The company was founded as a Delaware corporation in 1986 under the name Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006.

CEO

Christopher Lewis Stone

CEOChristopher Lewis Stone

Employees

—

Employees—

Headquarters

Reno, Nevada

HeadquartersReno, Nevada

Founded

1986

Founded1986

Employees

—

Employees—

PDLI Key Statistics

Market cap

233.85M

Market cap233.85M

Price-Earnings ratio

-1.81

Price-Earnings ratio-1.81

Dividend yield

—

Dividend yield—

Average volume

6.15M

Average volume6.15M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$2.52

52 Week high$2.52

52 Week low

$1.61

52 Week low$1.61